News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Deal between Freedom Meditech, Inc. and Battelle Could Lead to Breakthrough in Diabetes Management


2/28/2008 9:44:15 AM

SAN DIEGO & COLUMBUS, Ohio--(BUSINESS WIRE)--Freedom Meditech, Inc., a developer of a proprietary non-invasive ocular glucose measurement technology for people with diabetes, today announced an agreement with Battelle to begin an initial phase of development for a device for use in Food and Drug Administration (FDA)-compliant pilot human clinical studies.

Read at BioSpace.com


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES